Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
N/A
-7,639 Reduced 10.96%
62,035 $0
Q1 2023

May 11, 2023

SELL
N/A
-888 Reduced 1.26%
69,674 $0
Q4 2022

Feb 13, 2023

BUY
$0.0 - $15.9 $0 - $1.12 Million
70,562 New
70,562 $0

Others Institutions Holding MNKPF

# of Institutions
1
Shares Held
35K
Call Options Held
0
Put Options Held
0

About Mallinckrodt plc


  • Ticker MNKPF
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,170,900
  • Description
  • Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in...
More about MNKPF
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.